Information in the news releases is current on the date of the announcement, but is subject to change without prior notice.
2023 Release
-
December 26, 2023
DEVELOPMENT OF PREDICTION MODEL FOR BRAIN AMYLOID-BETA ACCUMULATION USING WRISTBAND SENSOR
-
December 18, 2023
-
December 13, 2023
-
December 13, 2023
-
December 9, 2023
-
November 30, 2023
EISAI’S SALES SUBSIDIARY COLLABORATES WITH MINISTRY OF PUBLIC HEALTH (MOPH) IN THAILAND
-
November 22, 2023
-
November 20, 2023
LEQEMBI® Wins Best New Drug And Clinical Advance Of The Year at The Scrip Awards 2023
-
November 16, 2023
-
October 26, 2023
-
October 25, 2023
LEQEMBI® (LECANEMAB-IRMB) NAMED ONE OF TIME’S BEST INVENTIONS OF 2023
-
October 16, 2023
-
October 11, 2023
EISAI TO PRESENT RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO CONGRESS 2023
-
October 4, 2023
-
September 28, 2023
-
September 28, 2023
TOKIO MARINE NICHIDO AND EISAI
CO-DEVELP INDUSTRY’S FIRST “DEMENTIA CARE SUPPORT INSURANCE” -
September 25, 2023
-
September 22, 2023
-
September 21, 2023
-
September 12, 2023
-
August 25, 2023
-
August 4, 2023
-
August 1, 2023
-
July 20, 2023
-
July 12, 2023
-
July 11, 2023
-
July 7, 2023
-
June 30, 2023
-
June 29, 2023
Position and Policy Regarding Reduction of the Investment Unit of the Company's Shares
-
June 29, 2023
-
June 22, 2023
-
June 10, 2023
-
June 8, 2023
-
June 6, 2023
-
June 2, 2023
EISAI TO PRESENT LATEST DATA ON LEMBOREXANT AT THE 37TH ANNUAL SLEEP 2023 MEETING
-
May 26, 2023
-
May 25, 2023
-
May 24, 2023
-
May 22, 2023
-
May 17, 2023
-
May 16, 2023
HEALTH CANADA ACCEPTS NEW DRUG SUBMISSION FOR LECANEMAB AS TREATMENT FOR EARLY ALZHEIMER’S DISEASE
-
May 15, 2023
-
May 15, 2023
-
May 9, 2023
-
May 8, 2023
-
April 7, 2023
-
April 6, 2023
-
April 4, 2023
-
April 3, 2023
-
March 31, 2023
-
March 31, 2023
-
March 24, 2023
-
March 23, 2023
-
March 20, 2023
-
March 14, 2023
-
March 10, 2023
EISAI RECEIVES THE “BASIC ACHIEVEMENT GRAND PRIZE” AT THE 2023 J-WIN DIVERSITY AWARD
-
March 9, 2023
EISAI CERTIFIED AS A 2023 HEALTH AND PRODUCTIVITY MANAGEMENT OUTSTANDING ORGANIZATION (WHITE 500)
-
March 6, 2023
-
March 2, 2023
BIOGEN JAPAN AND EISAI PROVIDE UPDATE ON CO-PROMOTION OF MULTIPLE SCLEROSIS TREATMENTS IN JAPAN
-
February 28, 2023
-
February 20, 2023
-
January 30, 2023
-
January 27, 2023
-
January 19, 2023
EISAI COMMENCES BUSINESS ACTIVITIES AT NEW PHARMA SALES SUBSIDIARY IN ISRAEL
-
January 18, 2023
-
January 18, 2023
-
January 16, 2023
-
January 13, 2023
-
January 11, 2023
-
January 7, 2023
-
January 7, 2023
Eisai’s Commitment to Scientific Evidence and Patient Safety
-
January 7, 2023
-
January 7, 2023